Related references
Note: Only part of the references are listed.Effect of NKG2D ligand expression on host immune responses
Marine Champsaur et al.
IMMUNOLOGICAL REVIEWS (2015)
Densely Granulated Murine NK Cells Eradicate Large Solid Tumors
Rebecca B. Liu et al.
CANCER RESEARCH (2012)
Fusion proteins between ligands for NKG2D and CD20-directed single-chain variable fragments sensitize lymphoma cells for natural killer cell-mediated lysis and enhance antibody-dependent cellular cytotoxicity
C. Kellner et al.
LEUKEMIA (2012)
Targeted Expression of Mutated ALK Induces Neuroblastoma in Transgenic Mice
Lukas C. Heukamp et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Lenalidomide enhances antibody-dependent cellular cytotoxicity of solid tumor cells in vitro: influence of host immune and tumor markers
Lei Wu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
Use of allogeneic NK cells for cancer immunotherapy
Melissa A. Geller et al.
IMMUNOTHERAPY (2011)
Mechanisms of Tumor and Viral Immune Escape from Natural Killer Cell-Mediated Surveillance
Ariane Groth et al.
JOURNAL OF INNATE IMMUNITY (2011)
Induction of In Vitro and In Vivo NK Cell Cytotoxicity Using High-Avidity Immunoligands Targeting Prostate-Specific Membrane Antigen in Prostate Carcinoma
Ron D. Jachimowicz et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Delivery of NKG2D Ligand Using an Anti-HER2 Antibody-NKG2D Ligand Fusion Protein Results in an Enhanced Innate and Adaptive Antitumor Response
Hyun-Mi Cho et al.
CANCER RESEARCH (2010)
Tumor-associated MICA is shed by ADAM proteases
Inja Waldhauer et al.
CANCER RESEARCH (2008)
NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma
Esther Moga et al.
EXPERIMENTAL HEMATOLOGY (2008)
NK cells interactions with dendritic cells shape innate and adaptive immunity
Fabienne Brilot et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Soluble NKG2D ligands: prevalence, release, and functional impact
Helmut Rainer Salih
Frontiers in Bioscience-Landmark (2008)
Induction of NKG2D ligands and subsequent enhancement of NK cell-mediated lysis of cancer cells by arsenic trioxide
Joo-Young Kim et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Natural killer cell-directed therapies: moving from unexpected results to successful strategies
Magali Terme et al.
NATURE IMMUNOLOGY (2008)
Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier
NATURE IMMUNOLOGY (2008)
The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor-positive tumor cells is enhanced by cytokines
Julie M. Roda et al.
CLINICAL CANCER RESEARCH (2007)
Regulation of the expression of MHC class I-related chain A, B (MICA, MICB) via chromatin remodeling and its impact on the susceptibility of leukemic cells to the cytotoxicity of NKG2D-expressing cells
N. Kato et al.
LEUKEMIA (2007)
Donor natural killer cell allorecognition of missing self in haploidentical hernatopoietic transplantation for acute myeloid leukemia: challenging its predictive value
Loredana Ruggeri et al.
BLOOD (2007)
Prospects for the use of NK cells in immunotherapy of human cancer
Hans-Gustaf Ljunggren et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self
Loredana Ruggeri et al.
IMMUNOLOGICAL REVIEWS (2006)
A novel bispecific protein (ULBP2-BB4) targeting the NKG2D receptor on natural killer (NK) cells and CD138 activates NK cells and has potent antitumor activity against human multiple myeloma in vitro and in vivo
EP von Strandmann et al.
BLOOD (2006)
Selective killing of B-cell hybridomas targeting proteinase 3, Wegener's autoantigen
KS Reiners et al.
IMMUNOLOGY (2004)
The crystal structure of an anti-CEA scFv diabody assembled from T84.66 scFvs inVL-to-VH orientation:: Implications for diabody flexibility
JA Carmichael et al.
JOURNAL OF MOLECULAR BIOLOGY (2003)
NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation
S Gilfillan et al.
NATURE IMMUNOLOGY (2002)
Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D
A Diefenbach et al.
NATURE IMMUNOLOGY (2002)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
Src-dependent Syk activation controls CD69-mediated signaling and function on human NK cells
S Pisegna et al.
JOURNAL OF IMMUNOLOGY (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
A Diefenbach et al.
NATURE (2001)
Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications
PJ Yazaki et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2001)
Tumor targeting of radiometal labeled anti-CEA recombinant T84.66 diabody and T84.66 minibody: Comparison to radioiodinated fragments
PJ Yazaki et al.
BIOCONJUGATE CHEMISTRY (2001)
Share Paper
